Cécile Matthews and Bhavesh Patel were quoted in Pink Sheet regarding their analysis entitled “How do rare disease patient numbers in Germany affect prices for non-oncology orphan drugs?” In Pink Sheet, Matthews and Patel discuss factors to consider when agreeing on a price including benefit ratings, patient populations, and budget impact.
Supporting appropriate recognition and action for vaccination in AMR National Action Plans
Antimicrobial Resistance (AMR) is a serious and increasing threat to global health security and impacts the efficacy of medicines we have come to rely on, made...